FLOWER MOUND, TX / ACCESSWIRE / August 18, 2022 / Black Bird Biotech, Inc. (ROSA OTC:BBBT)manufacturer and distributor of vegetable products MiteXstreamTM biopesticide, announced that it has signed a distribution agreement for its Grizzly Creek NaturalsTM CBD product line with Chicago-based Beyond Das Skin, a national distributor of luxury spa products. During its more than 40 years of distribution operations, Beyond Das Skin has established a product distribution network covering Chicago, Las Vegas, New York, Texas and the East Coast of Florida.
Beyond Das Skin owner Andreas Jungermann said: “I’m really excited to add the Grizzly Creek NaturalsTM line in our constantly growing catalog. It fills our CBD void while offering the same high-quality, spa-level product that we are proud to sell to our customers. The CBD industry is a rapidly growing market in which we can and will have a significant impact. We look forward to distributing through Black Bird Biotech.”
“We are very pleased that Andreas and his team at Beyond Das Skin are taking it on Grizzly Creek NaturalsTM CBD products in markets across the country. Their sincere approach to achieving this agreement, along with their sense of ‘team’, has instilled in us great confidence in our future together,” said Fabian Deneault, president of BBBT. “The work on redesigning the our labels and Grizzly Creek NaturalsTM The website, which will mark a return to our ‘Big Sky Montana’ themes of the past, is nearing completion, and we believe this will allow our CBD products to fit seamlessly into their channel within the offering widest range of products from Beyond Das Skin”.
According to an April 2022 report by Global Market Insights, the CBD market reached $12.8 billion in 2021 and is expected to grow at a CAGR of 21.7% between 2022 and 2028. This expected growth it is attributed to the increased awareness of the health benefits of CBD and its effectiveness in the treatment of pain and other treatments. Additionally, pet welfare is becoming a major driver of CBD sales growth.
For news and updates, shareholders, potential investors and potential business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit the BBBT corporate website, BlackBirdBiotech.comfor additional information about the company.
About Beyond Das Skin
Beyond das Skin is a family business offering luxury spa products for the whole family. Whether you’re looking for a relaxing girls’ night out, the perfect shave, or the kids’ bubble bath 5-star fun, Beyond das Skin brings the Spa and Salon feel to your home. With 40 years of experience in providing services to spas, salons, golf courses and sports clubs in the United States, owner Andreas Jungermann has developed relationships with vendors and equipment managers to distribute in Chicago, Las Vegas, New York , Texas and the east. coast of Florida
About BBBT
Black Bird Biotech is positioned to exploit market segments with powerful and reimagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including mites (a lethal pest of cannabis, grapes, hops, coffee, strawberries and many other agricultural crops) and kills molds and the blooms MiteXstreamTM is a pesticide, but it’s not a poison, it’s a pesticide reimagined. MiteXstreamTM Edges: Bee SAFE and can be used on harvest day without worrying about residual “pesticide” violations, even for state cannabis testing. MiteXstreamTM is the cornerstone of the company that has great potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional “poisonous” pesticides.
Forward-looking statements:
This current press release contains “forward-looking statements” as such term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements of These press releases are not only historical but are forward-looking statements and include any statements about beliefs, plans, expectations or intentions regarding the future, including, but not limited to, any products sold or cash flows from operations.
Actual results could differ from those projected in any forward-looking statement due to numerous factors. These factors include, but are not limited to, the inherent uncertainties associated with distribution and the difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this press release, and we undertake no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should review all of the information set forth herein and should also review our most recent annual report for the most recent fiscal year, our quarterly reports and other periodic reports filed from time to time with the Securities and Exchange Commission.
CONTACT:
Eric Newlan
Vice President
833-223-4204
[email protected]
BlackBirdBiotech.com
SOURCE: Black Bird Biotech, Inc.
View the source version at accesswire.com: